Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
8,017
Views
100
CrossRef citations to date
0
Altmetric
Articles

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Hua-Long Xionga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Yang-Tao Wua State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Jia-Li Caoa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Ren Yangb NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, People’s Republic of ChinaView further author information
,
Ying-Xia Liuc Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Jian Maa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Xiao-Yang Qiaoa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Xiang-Yang Yaod The First Hospital of Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Bao-Hui Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Ya-Li Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Wang-Heng Houa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Yang Shia State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Jing-Jing Xue Department of Hematology, Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fuzhou, People’s Republic of ChinaView further author information
,
Liang Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Shao-Juan Wanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Bao-Rong Fua State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Ting Yange Department of Hematology, Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fuzhou, People’s Republic of ChinaView further author information
,
Sheng-Xiang Gea State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Jun Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Quan Yuana State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5487-561XView further author information
ORCID Icon,
Bao-Ying Huangb NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Zhi-Yong Lid The First Hospital of Xiamen University, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Tian-Ying Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Ning-Shao Xiaa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Sciences, Xiamen University, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0179-5266View further author information
ORCID Icon show all
Pages 2105-2113 | Received 01 May 2020, Accepted 24 Aug 2020, Published online: 24 Sep 2020

Citations (100)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Syamala R. Thimmiraju, Jason T. Kimata & Jeroen Pollet. (2024) Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses. Expert Review of Vaccines 23:1, pages 174-185.
Read now
Zhigang Liu, Jiahui Liang, Hangzhan Hu, Mengli Wu, Jingjing Ma, Ziwei Ma, Jianing Ji, Hengyi Chen, Xiaoquan Li, Zhizeng Wang & Yang Luo. (2023) Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis. International Journal of Nanomedicine 18, pages 3125-3139.
Read now
Ziteng Liang, Xi Wu, Jiajing Wu, Shuo Liu, Jincheng Tong, Tao Li, Yuanling Yu, Li Zhang, Chenyan Zhao, Qiong Lu, Haiyang Qin, Jianhui Nie, Weijin Huang & Youchun Wang. (2023) Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector. Emerging Microbes & Infections 12:2.
Read now

Articles from other publishers (97)

Xiaowei Sheng, Jin Wang, Luling Zhao, Wenjing Yan, Jing Qian, Zhaobin Wang, Jianhao Zhang & Vijaya Raghavan. (2024) Inactivation mechanism of cold plasma combined with 222 nm ultraviolet for spike protein and its application in disinfecting of SARS-CoV-2. Journal of Hazardous Materials 465, pages 133458.
Crossref
Xiuli Zhang, Mingjing Wei, Zhigang Zhang, Yarong Zeng, Feihong Zou, Sibo Zhang, Zhiping Wang, Fentian Chen, Hualong Xiong, Yufang Li, Lizhi Zhou, Tingting Li, Qingbing Zheng, Hai Yu, Jun Zhang, Ying Gu, Qinjian Zhao, Shaowei Li & Ningshao Xia. (2024) Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy. Journal of Controlled Release 367, pages 13-26.
Crossref
Fatemeh Yaghoobizadeh, Mohammad Roayaei Ardakani, Mohammad Mehdi Ranjbar, Mohammad Khosravi & Hamid Galehdari. (2024) Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development. Computers in Biology and Medicine 170, pages 108091.
Crossref
Hui Sun, Tingting Deng, Yali Zhang, Yanling Lin, Yanan Jiang, Yichao Jiang, Yang Huang, Shuo Song, Lingyan Cui, Tingting Li, Hualong Xiong, Miaolin Lan, Liqin Liu, Yu Li, Qianjiao Fang, Kunyu Yu, Wenling Jiang, Lizhi Zhou, Yuqiong Que, Tianying Zhang, Quan Yuan, Tong Cheng, Zheng Zhang, Hai Yu, Jun Zhang, Wenxin Luo, Shaowei Li, Qingbing Zheng, Ying Gu & Ningshao Xia. (2024) Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD. Protein & Cell 15:2, pages 121-134.
Crossref
Meifeng Nie, Shuyu Wu, Yiyi Chen, Yangtao Wu, Ruitong Chen, Yue Liu, Mingxi Yue, Yao Jiang, Dekui Qiu, Man Yang, Zikang Wang, Jiahua Gao, Hualong Xiong, Ruoyao Qi, Jinhang He, Jinlei Zhang, Liang Zhang, Yingbin Wang, Mujin Fang, Yuqiong Que, Youliang Yao, Shaowei Li, Jun Zhang, Qinjian Zhao, Quan Yuan, Tianying Zhang & Ningshao Xia. (2024) Micronanoparticled risedronate exhibits potent vaccine adjuvant effects. Journal of Controlled Release 365, pages 369-383.
Crossref
Xiaoya Guo, Xing Lv, Yunfu Wu, Mingming Wang, Shuo Wu, Li Guo, Zifeng Wang, Zhihong Shi, Rui Huang, Hua Zhang, Xiaona Niu, Mingzhe Rong, Liqiang Song & Dingxin Liu. (2023) Safety and efficacy of plasma‐activated water on prolonged viral shedding of COVID‐19 patients: A randomized controlled trial. Plasma Processes and Polymers.
Crossref
Narayanaiah Cheedarla, Hans P. Verkerke, Sindhu Potlapalli, Kaleb Benjamin McLendon, Anamika Patel, Filipp Frank, William Henry O’Sick, Suneethamma Cheedarla, Tyler Jon Baugh, Gregory L. Damhorst, Huixia Wu, Daniel Graciaa, Fuad Hudaib, David N. Alter, Janetta Bryksin, Eric A. Ortlund, Jeanette Guarner, Sara Auld, Sarita Shah, Wilbur Lam, Dawn Mattoon, Joseph M. Johnson, David H. Wilson, Madhav V. Dhodapkar, Sean R. Stowell, Andrew S. Neish & John D. Roback. (2023) Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers. iScience 26:11, pages 108256.
Crossref
Diego Cantoni, Craig Wilkie, Emma M. Bentley, Martin Mayora-Neto, Edward Wright, Simon Scott, Surajit Ray, Javier Castillo-Olivares, Jonathan Luke Heeney, Giada Mattiuzzo & Nigel James Temperton. (2023) Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Frontiers in Immunology 14.
Crossref
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, Li Liu, Qiwen Liu, Yiyin Mai, Huihuang Chen, Baoying Lei, Shangwei Yu, Huihui Chen, Peiyan Zheng & Baoqing Sun. (2023) SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges. Reviews in Medical Virology 33:5.
Crossref
Christopher W Dukes, Renata AM Rossetti, Jonathan A Hensel, Sebastian Snedal, Christopher L Cubitt, Michael J Schell, Martha Abrahamsen, Kimberly Isaacs-Soriano, Kayoko Kennedy, Leslie N Mangual, Junmin Whiting, Veronica Martinez-Brockhus, Jessica Y Islam, Julie Rathwell, Matthew Beatty, Amy M Hall, Daniel Abate-Daga, Anna R Giuliano & Shari Pilon-Thomas. (2023) SARS-CoV-2 antibody response duration and neutralization following natural infection. Journal of Clinical Virology Plus 3:3, pages 100158.
Crossref
Chunxia Chen, Jiahui Liang, Hangzhan Hu, Xiaoquan Li, Li Wang & Zhizeng Wang. (2023) Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2. Analytical Biochemistry 673, pages 115199.
Crossref
Alessandro Maglione, Rachele Francese, Irene Arduino, Rachele Rosso, Manuela Matta, Simona Rolla, David Lembo & Marinella Clerico. (2023) Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis. Frontiers in Immunology 14.
Crossref
Seung Bum Park, Mohsin Khan, Sai Chaitanya Chiliveri, Xin Hu, Parker Irvin, Madeleine Leek, Ailis Grieshaber, Zongyi Hu, Eun Sun Jang, Ad Bax & T. Jake Liang. (2023) SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Communications Biology 6:1.
Crossref
Ying Zhang, Yixiao Chen, Yong He, Yizhe Li, Xiaoli Zhang, Jiajie Liang, Jinyong He, Shaofang Lu, Zhixing Gao, Jianhua Xu & Yong Tang. (2023) Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test. Talanta 255, pages 124200.
Crossref
Lizhou Zhang, Nancy Hom, Amrita Ojha, Klaus N. Lovendahl, Huihui Mou, Kelly K. Lee & Hyeryun Choe. (2023) Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions. Journal of Virology 97:3.
Crossref
Mingtao Liu, Hui Gan, Zhiman Liang, Li Liu, Qiwen Liu, Yiyin Mai, Huihuang Chen, Baoying Lei, Shangwei Yu, Huihui Chen, Peiyan Zheng & Baoqing Sun. (2023) Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies. Frontiers in Microbiology 14.
Crossref
Lin Xia, Lun-zhi Yuan, Ya-hong Hu, Jun-yi Liu, Guo-sheng Hu, Ruo-yao Qi, Tian-ying Zhang, Hua-long Xiong, Zao-zao Zheng, Hong-wei Lin, Jia-mo Zhang, Chao Yu, Ming Zhou, Jian Ma, Tong Cheng, Ri-rong Chen, Yi Guan, Ning-shao Xia & Wen Liu. (2023) A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19. Cellular & Molecular Immunology 20:4, pages 351-364.
Crossref
Fatemeh Yaghoobizadeh, Mohammad Roayaei Ardakani, Mohammad Mehdi Ranjbar, Hamid Galehdari & Mohammad Khosravi. (2023) Expression, purification, and study on the efficiency of a new potent recombinant scFv antibody against the SARS-CoV-2 spike RBD in E. coli BL21. Protein Expression and Purification 203, pages 106210.
Crossref
Zeng Wang, Kunhong Zhong, Guoqing Wang, Qizhong Lu, Hexian Li, Zhiguo Wu, Zongliang Zhang, Nian Yang, Meijun Zheng, Yuelong Wang, Chunlai Nie, Liangxue Zhou & Aiping Tong. (2023) Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection. Gene 856, pages 147144.
Crossref
Zhen Xiao, Huan Xu, Ze-yang Qu, Xin-yuan Ma, Bo-xuan Huang, Meng-si Sun, Bu-qing Wang & Guan-yu Wang. (2022) Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants. Chinese Journal of Integrative Medicine 29:3, pages 205-212.
Crossref
Entao Li, Qiuxue Han, Jinhao Bi, Shimeng Wei, Shen Wang, Ying Zhang, Jun Liu, Na Feng, Tiecheng Wang, Jun Wu, Songtao Yang, Yongkun Zhao, Bo Liu, Feihu Yan & Xianzhu Xia. (2023) Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection. Frontiers in Immunology 14.
Crossref
Rebecca Galla, Sara Ferrari, Sara Ruga, Beatrice Mantuano, Giorgia Rosso, Stelvio Tonello, Luigi Rosa, Piera Valenti & Francesca Uberti. (2023) Effects of Usnic Acid to Prevent Infections by Creating a Protective Barrier in an In Vitro Study. International Journal of Molecular Sciences 24:4, pages 3695.
Crossref
Wenwen He, Huan Cui, Shen Wang, Bo Liang, Cheng Zhang, Weiqi Wang, Qi Wang, Wujian Li, Yongkun Zhao, Tiecheng Wang, Zhuoran Liu, Bin Liu, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant. Microorganisms 11:2, pages 431.
Crossref
Yuexin Lv, Shuai Ge, Qiumei Zhu, Min Si, Cheng Wang & Huaizhen He. (2023) Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2. New Journal of Chemistry 47:5, pages 2651-2658.
Crossref
Bo Gao, Liheng He, Yujie Bao, Yingying Chen, Guanzhu Lu, Yu Zhang, Yingjie Xu, Bing Su, Jie Xu, Ying Wang & Leng-Siew Yeap. (2023) Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection. Cell Research 33:3, pages 258-261.
Crossref
John Merluza, Johnny Ung, Kai Makowski, Alyssia Robinson, Kathy Manguiat, Nicole Mueller, Jonathan Audet, Julie Chih-Yu Chen, James E. Strong, Heidi Wood & Alexander Bello. (2023) Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiology Spectrum.
Crossref
Yongliang Zhao, Wenjia Ni, Simeng LiangLianghui DongMin Xiang, Zeng CaiDanping Niu, Qiuhan ZhangDehe Wang, Yucheng ZhengZhen ZhangDan Zhou, Wenhua GuoYongbing PanXiaoli WuYimin Yang, Zhaofei JingYongzhong JiangYu Chen, Huan Yan, Yu Zhou, Ke Xu & Ke Lan. (2023) Vaccination with S pan , an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice . Science Translational Medicine 15:677.
Crossref
Ke Jiang, Simeng Liang, Xiaojuan Sun, Jianwei Ben, Liang Qu, Shanli Zhang, Yang Chen, Yucheng Zheng, Ke Lan, Dabing Li & Ke Xu. (2023) Rapid inactivation of human respiratory RNA viruses by deep ultraviolet irradiation from light-emitting diodes on a high-temperature-annealed AlN/Sapphire template. Opto-Electronic Advances 6:9, pages 230004-230004.
Crossref
Jeonghui Moon, Younghun Jung, Seokoh Moon, Jaehyeon Hwang, Soomin Kim, Mi Soo Kim, Jeong Hyeon Yoon, Kyeongwon Kim, Youngseo Park, Jae Youl Cho & Dae-Hyuk Kweon. (2023) Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng. Journal of Ginseng Research 47:1, pages 123-132.
Crossref
Panke Qu, John P. Evans, Julia N. Faraone, Yi-Min Zheng, Claire Carlin, Mirela Anghelina, Patrick Stevens, Soledad Fernandez, Daniel Jones, Gerard Lozanski, Ashish Panchal, Linda J. Saif, Eugene M. Oltz, Kai Xu, Richard J. Gumina & Shan-Lu Liu. (2023) Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host & Microbe 31:1, pages 9-17.e3.
Crossref
Meiyu Wang, Jianhui Nie & Youchun Wang. 2023. Pseudotyped Viruses. Pseudotyped Viruses 133 151 .
Youchun Wang, Zehua Zhou, Xi Wu, Tao Li, Jiajing Wu, Meina Cai, Jianhui Nie, Wenbo Wang & Zhimin Cui. 2023. Pseudotyped Viruses. Pseudotyped Viruses 1 27 .
Caitlin A. Williams, Teri Ann S. Wong, Aquena H. Ball, Michael M. Lieberman & Axel T. Lehrer. (2022) Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model. Viruses 14:12, pages 2784.
Crossref
Yangtao Wu, Shaojuan Wang, Yali Zhang, Lunzhi Yuan, Qingbing Zheng, Min Wei, Yang Shi, Zikang Wang, Jian Ma, Kai Wang, Meifeng Nie, Jin Xiao, Zehong Huang, Peiwen Chen, Huilin Guo, Miaolin Lan, Jingjing Xu, Wangheng Hou, Yunda Hong, Dabing Chen, Hui Sun, Hualong Xiong, Ming Zhou, Che Liu, Wenjie Guo, Huiyu Guo, Jiahua Gao, Congling Gan, Zhixiong Li, Haitao Zhang, Xinrui Wang, Shaowei Li, Tong Cheng, Qinjian Zhao, Yixin Chen, Ting Wu, Tianying Zhang, Jun Zhang, Hua Cao, Huachen Zhu, Quan Yuan, Yi Guan & Ningshao Xia. (2022) Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host & Microbe 30:12, pages 1732-1744.e7.
Crossref
Yuksel Cetin, Seyma Aydinlik, Aysen Gungor, Tugce Kan, Timucin Avsar & Serdar Durdagi. (2022) Review on In Silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2 . Current Medicinal Chemistry 29:38, pages 5925-5948.
Crossref
Tingting Deng, Tingting Li, Gege Chen, Yuhe Zhu, Lang Xu, Yanlin Lin, Hui Sun, Hui Zhang, Qianjiao Fang, Junping Hong, Dinghui Wu, Shuangquan Gao, Shaoyong Li, Yingbin Wang, Tianying Zhang, Yixin Chen, Quan Yuan, Qingbing Zheng, Hai Yu, Qinjian Zhao, Jun Zhang, Shaowei Li, Ningshao Xia & Ying Gu. (2022) Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation. Vaccine 40:47, pages 6839-6848.
Crossref
Siling Wang, Yangling Wu, Yizhen Wang, Zihao Chen, Dong Ying, Xue Lin, Chang Liu, Min Lin, Jinlei Zhang, Yuhe Zhu, Shaoqi Guo, Huixian Shang, Xiuting Chen, Hongsheng Qiang, Yifan Yin, Zimin Tang, Zizheng Zheng & Ningshao Xia. (2022) Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection. Journal of Virological Methods 309, pages 114597.
Crossref
José Antonio Cruz-Cardenas, Michelle Gutierrez, Alejandra López-Arredondo, Julio Enrique Castañeda-Delgado, Augusto Rojas-Martinez, Yukio Nakamura, José Antonio Enciso-Moreno, Laura A. Palomares & Marion E. G. Brunck. (2022) A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept. Scientific Reports 12:1.
Crossref
Sneha Ratnapriya, Anthony R. Braun, Héctor Cervera Benet, Danielle Carlson, Shilei Ding, Carolyn N. Paulson, Neeraj Mishra, Jonathan N. Sachs, Courtney C. Aldrich, Andrés Finzi & Alon Herschhorn. (2022) Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry. ACS Infectious Diseases 8:10, pages 2045-2058.
Crossref
Mengyuan Chen, Shuizhen He, Hualong Xiong, Dongxu Zhang, Shaojuan Wang, Wangheng Hou, Xiaomei Zhu, Jin Wang, Yang Huang, Congming Hong, Yubin Wu, Ruoyao Qi, Tianying Zhang, Quan Yuan, Tingdong Li, Yixin Chen, Shiyin Zhang, Shengxiang Ge, Jun Zhang & Ningshao Xia. (2022) New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq. Virologica Sinica 37:5, pages 758-761.
Crossref
Marcel Jaron, Michael Lehky, Marta Zarà, Chris Nicole Zaydowicz, Aidin Lak, Rico Ballmann, Philip Alexander Heine, Esther Veronika Wenzel, Kai-Thomas Schneider, Federico Bertoglio, Susanne Kempter, Reinhard Wolfgang Köster, Silvia Stella Barbieri, Joop van den Heuvel, Michael Hust, Stefan Dübel & Maren Schubert. (2022) Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment. Viruses 14:10, pages 2087.
Crossref
Dongping Zhao, Liqin Liu, Xinlin Liu, Jinlei Zhang, Yuqing Yin, Linli Luan, Dingwen Jiang, Xiong Yang, Lei Li, Hualong Xiong, Dongming Xing, Qingbing Zheng, Ningshao Xia, Yuyong Tao, Shaowei Li & Haiming Huang. (2022) A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode. Journal of Nanobiotechnology 20:1.
Crossref
Faezeh Maghsood, Mohammad Mehdi Amiri, Amir-Hassan Zarnani, Vahid Salimi, Gholam Ali Kardar, Jalal Khoshnoodi, Maryam Mobini, Hengameh Ahmadi Zare, Abbas Ghaderi, Mahmood Jeddi-Tehrani, Sylvie Schmidt, Géraldine Laumond, Christiane Moog & Fazel Shokri. (2022) Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies. Frontiers in Medicine 9.
Crossref
Hui Zhang, Tingting Deng, Qianjiao Fang, Shaoyong Li, Shuangquan Gao, Wenling Jiang, Gege Chen, Kunyu Yu, Lizhi Zhou, Tingting Li, Qingbing Zheng, Hai Yu, Shaowei Li, Ningshao Xia & Ying Gu. (2022) Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses. Virology 574, pages 1-8.
Crossref
Hualong Xiong, Hui Sun, Siling Wang, Lunzhi Yuan, Liqin Liu, Yuhe Zhu, Jinlei Zhang, Yang Huang, Ruoyao Qi, Yao Jiang, Jian Ma, Ming Zhou, Yue Ma, Rao Fu, Siping Yan, Mingxi Yue, Yangtao Wu, Min Wei, Yizhen Wang, Tingting Li, Yingbin Wang, Zizheng Zheng, Hai Yu, Tong Cheng, Shaowei Li, Quan Yuan, Jun Zhang, Yi Guan, Qingbing Zheng, Tianying Zhang & Ningshao Xia. (2022) The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2. Proceedings of the National Academy of Sciences 119:34.
Crossref
Chih-Feng Tien, Wan-Ting Tsai, Chun Hwa Chen, Hui-Ju Chou, Mingzi M. Zhang, Jhe-Jhih Lin, En-Ju Lin, Shih-Syong Dai, Yueh-Hsin Ping, Chia-Yi Yu, Yi-Ping Kuo, Wei-Hsiang Tsai, Hsin-Wei Chen & Guann-Yi Yu. (2022) Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking. iScience 25:8, pages 104709.
Crossref
Sabine Lichtenegger, Sabine Saiger, Melina Hardt, Susanne Kulnik, Gabriel E. Wagner, Barbara Kleinhappl, Karoline Assig, Andrea Zauner, Michelle Ober, Janine Kimpel, Dorothee von Laer, Kurt Zatloukal & Ivo Steinmetz. (2022) Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout. Journal of Clinical Microbiology 60:7.
Crossref
Kuan-Ting Liu, Yi-Ju Han, Guan-Hong Wu, Kuan-Ying A. Huang & Peng-Nien Huang. (2022) Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody. Viruses 14:7, pages 1560.
Crossref
Wen Jiang, Zherui Zhang, Yuhe Zhu, Ben Chen, Chunying Gu, Zhiyan Liu, Xukai Zhang, Hualong Xiong, Yanan Zhang, Bin Zheng, Rongjuan Wang, Shasha Jiao, An Wang, Tianying Zhang, Jinchao Zhang, Shuang Wang, Bo Zhang, Gang Li & Xun Gui. (2022) Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage. Frontiers in Pharmacology 13.
Crossref
Jeswin Joseph, Thankamani Karthika, Valiyathara Rajan Akshay Das & Victor Stalin Raj. (2022) The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction. Current Pharmaceutical Biotechnology 23:8, pages 1118-1129.
Crossref
Hancong Sun, Jinghan Xu, Guanying Zhang, Jin Han, Meng Hao, Zhengshan Chen, Ting Fang, Xiangyang Chi & Changming Yu. (2022) Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants. Viruses 14:6, pages 1332.
Crossref
Jhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, En-Ju Lin, Wei-Hsiang Tsai, Ming-Yu Chen, Pei-Ju Tsai, Yu-Wen Su, Nikhil Pathak, Jinn-Moon Yang, Chia-Yi Yu, Zih-Shiuan Chuang, Han-Chieh Wu, Wan-Ting Tsai, Shih-Syong Dai, Hung-Chun Liao, Kit Man Chai, Yu-Siang Su, Tsung-Hsien Chuang, Shih-Jen Liu, Hsin-Wei Chen, Horng-Yunn Dou, Feng-Jui Chen, Chiung-Tong Chen, Chin-Len Liao & Guann-Yi Yu. (2022) Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection. Frontiers in Immunology 13.
Crossref
Siling Wang, Hui Sun, Yali Zhang, Lunzhi Yuan, Yizhen Wang, Tianying Zhang, Shaojuan Wang, Jinlei Zhang, Hai Yu, Hualong Xiong, Zimin Tang, Liqin Liu, Yang Huang, Xiuting Chen, Tingting Li, Dong Ying, Chang Liu, Zihao Chen, Quan Yuan, Jun Zhang, Tong Cheng, Shaowei Li, Yi Guan, Qingbing Zheng, Zizheng Zheng & Ningshao Xia. (2022) Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron. Cell Reports 39:8, pages 110862.
Crossref
Liqin Liu, Tingting Chen, Lizhi Zhou, Jie Sun, Yuqian Li, Meifeng Nie, Hualong Xiong, Yuhe Zhu, Wenhui Xue, Yangtao Wu, Tingting Li, Tianying Zhang, Zhibo Kong, Hai Yu, Jun Zhang, Ying Gu, Qingbing Zheng, Qinjian Zhao, Ningshao Xia & Shaowei Li. (2022) A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice. Frontiers in Microbiology 13.
Crossref
Shuangzhe Zhang, Chunhui Gao, Tuhin Das, Shuhong Luo, Hao Tang, Xinyi Yao, Chih Yun Cho, Jingqiao Lv, Kino Maravillas, Valerie Jones, Xiaofeng Chen & Ruopan Huang. (2022) The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies. Journal of Immunological Methods 503, pages 113244.
Crossref
Idan Ashur, Joel Alter, Michal Werbner, Abraham Ogungbile, Moshe Dessau, Meital Gal-Tanamy & Sefi Vernick. (2022) Rapid electrochemical immunodetection of SARS-CoV-2 using a pseudo-typed vesicular stomatitis virus model. Talanta 239, pages 123147.
Crossref
Seung Bum Park, Parker Irvin, Zongyi Hu, Mohsin Khan, Xin Hu, Qiru Zeng, Catherine Chen, Miao Xu, Madeleine Leek, Ruochen Zang, James Brett Case, Wei Zheng, Siyuan Ding & T. Jake Liang. (2022) Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio 13:1.
Crossref
Serdar Durdagi, Timucin Avsar, Muge Didem Orhan, Muge Serhatli, Bertan Koray Balcioglu, Hasan Umit Ozturk, Alisan Kayabolen, Yuksel Cetin, Seyma Aydinlik, Tugba Bagci-Onder, Saban Tekin, Hasan Demirci, Mustafa Guzel, Atilla Akdemir, Seyma Calis, Lalehan Oktay, Ilayda Tolu, Yasar Enes Butun, Ece Erdemoglu, Alpsu Olkan, Nurettin Tokay, Şeyma Işık, Aysenur Ozcan, Elif Acar, Sehriban Buyukkilic & Yesim Yumak. (2022) The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies. Molecular Therapy 30:2, pages 963-974.
Crossref
Yang Yi, Junhua Li, Xinyuan Lai, Meng Zhang, Yi Kuang, Yang-Oujie Bao, Rong Yu, Wei Hong, Elishiba Muturi, Heng Xue, Hongping Wei, Tong Li, Hui Zhuang, Xue Qiao, Kuanhui Xiang, Hang Yang & Min Ye. (2022) Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection. Journal of Advanced Research 36, pages 201-210.
Crossref
Marcela Salazar-García, Samyr Acosta-Contreras, Griselda Rodríguez-Martínez, Armando Cruz-Rangel, Alejandro Flores-Alanis, Genaro Patiño-López & Victor M. Luna-Pineda. (2022) Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019. Frontiers in Microbiology 12.
Crossref
Wei Ye, Xiaoyu Liu, Ruiting He, Liming Gou, Ming Lu, Gang Yang, Jiaqi Wen, Xufei Wang, Fang Liu, Sujuan Ma, Weifeng Qian, Shaochang Jia, Tong Ding, Luan Sun & Wei Gao. (2022) Improving antibody affinity through <i>in vitro</i> mutagenesis in complementarity determining regions. The Journal of Biomedical Research 36:3, pages 155.
Crossref
Sera Lim, Yuil Lee, Dong Wan Kim, Won Sang Park, Jung Hwan Yoon & Jung Young Lee. (2022) Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers. Infection & Chemotherapy 54:1, pages 140.
Crossref
Qiao Wang, Lili Feng, Haohai Zhang, Juehua Gao, Changchuin Mao, Esther Landesman-Bollag, Gustavo Mostoslavsky, Justin M Lunderberg, Weina Zheng, Shushun Hao & Wenda Gao. (2022) Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test. Antibody Therapeutics 5:1, pages 55-62.
Crossref
Zhen Wang, Lei Xiang, Feng Lin, Zhengwei Cai, Huitong Ruan, Juan Wang, Jing Liang, Fei Wang, Min Lu & Wenguo Cui. (2022) Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter 5:1, pages 336-362.
Crossref
Corey Balinsky, Vihasi Jani, Peifang Sun, Maya Williams, Gabriel Defang & Kevin R. Porter. 2022. SARS-CoV-2. SARS-CoV-2 361 378 .
Xujiao Ren, Ping Qian, Shudan Liu, Huanchun Chen & Xiangmin Li. (2021) Fc-Mediated E2-Dimer Subunit Vaccines of Atypical Porcine Pestivirus Induce Efficient Humoral and Cellular Immune Responses in Piglets. Viruses 13:12, pages 2443.
Crossref
Jinbiao Liu, Brittany H. Bodnar, Fengzhen Meng, Adil I. Khan, Xu Wang, Sami Saribas, Tao Wang, Saroj Chandra Lohani, Peng Wang, Zhengyu Wei, Jinjun Luo, Lina Zhou, Jianguo Wu, Guangxiang Luo, Qingsheng Li, Wenhui Hu & Wenzhe Ho. (2021) Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell & Bioscience 11:1.
Crossref
Yuning Shang, Feixiang Chen, Shasha Li, Lijuan Song, Yunzhen Gao, Xinhua Yu & Junfeng Zheng. (2021) Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System. Biological Procedures Online 23:1.
Crossref
Jo-Lewis Banga Ndzouboukou, Yan-di Zhang & Xiong-lin Fan. (2021) Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods. Current Medical Science 41:6, pages 1052-1064.
Crossref
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Paola Carolina Torres-Hernández & Jorge Hernández-Bello. (2021) Overview of Neutralizing Antibodies and Their Potential in COVID-19. Vaccines 9:12, pages 1376.
Crossref
Hung Caohuy, Ofer Eidelman, Tinghua Chen, Shufeng Liu, Qingfeng Yang, Alakesh Bera, Nathan I. Walton, Tony T. Wang & Harvey B. Pollard. (2021) Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Scientific Reports 11:1.
Crossref
Hsu-Yu Chen, Chun Huang, Lu Tian, Xiaoli Huang, Chennan Zhang, George N. Llewellyn, Geoffrey L. Rogers, Kevin Andresen, Maurice R. G. O’Gorman, Ya-Wen Chen & Paula M. Cannon. (2021) Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation. Journal of Virology 95:22.
Crossref
Li Guo, Zhiqian Yao, Lu Yang, Hao Zhang, Yu Qi, Lu Gou, Wang Xi, Dingxin Liu, Lei Zhang, Yilong Cheng, Xiaohua Wang, Mingzhe Rong, Hailan Chen & Michael G. Kong. (2021) Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection. Chemical Engineering Journal 421, pages 127742.
Crossref
Nadine Krüger, Cheila Rocha, Sandra Runft, Johannes Krüger, Iris Färber, Federico Armando, Eva Leitzen, Graham Brogden, Gisa Gerold, Stefan Pöhlmann, Markus Hoffmann & Wolfgang Baumgärtner. (2021) The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection. International Journal of Molecular Sciences 22:19, pages 10636.
Crossref
Tingting Li, Wenhui Xue, Qingbing Zheng, Shuo Song, Chuanlai Yang, Hualong Xiong, Sibo Zhang, Minqing Hong, Yali Zhang, Hai Yu, Yuyun Zhang, Hui Sun, Yang Huang, Tingting Deng, Xin Chi, Jinjin Li, Shaojuan Wang, Lizhi Zhou, Tingting Chen, Yingbin Wang, Tong Cheng, Tianying Zhang, Quan Yuan, Qinjian Zhao, Jun Zhang, Jason S. McLellan, Z. Hong Zhou, Zheng Zhang, Shaowei Li, Ying Gu & Ningshao Xia. (2021) Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants. Nature Communications 12:1.
Crossref
Nitesh Mishra, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar, Sankar Bhattacharyya, Jayanth Kumar Palanichamy, Riyaz Ahmad Mir, Subrata Sinha & Kalpana Luthra. (2021) Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. PLOS Pathogens 17:9, pages e1009958.
Crossref
Yuying Lu, Jin Wang, Qianlin Li, Huan Hu, Jiahai Lu & Zeliang Chen. (2021) Advances in Neutralization Assays for SARS‐CoV‐2. Scandinavian Journal of Immunology 94:3.
Crossref
Peng Yang, Yang Yang, Yuming Wu, Cong Huang, Yanlei Ding, Xuejun Wang & Shengqi Wang. (2021) An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research. Journal of Virological Methods 295, pages 114221.
Crossref
Yangtao Wu, Xiaofen HuangLunzhi Yuan, Shaojuan WangYali Zhang, Hualong XiongRirong Chen, Jian Ma, Ruoyao Qi, Meifeng NieJingjing Xu, Zhigang Zhang, Liqiang Chen, Min Wei, Ming ZhouMinping Cai, Yang Shi, Liang ZhangHuan YuJunping HongZikang WangYunda Hong, Mingxi YueZonglin LiDabing Chen, Qingbing Zheng, Shaowei Li, Yixin Chen, Tong Cheng, Jun Zhang, Tianying Zhang, Huachen Zhu, Qinjian Zhao, Quan Yuan, Yi Guan & Ningshao Xia. (2021) A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters. Science Translational Medicine 13:606.
Crossref
Fangyu Zhang, Zhengxing Li, Lu Yin, Qiangzhe Zhang, Nelly Askarinam, Rodolfo Mundaca-Uribe, Farshad Tehrani, Emil Karshalev, Weiwei Gao, Liangfang Zhang & Joseph Wang. (2021) ACE2 Receptor-Modified Algae-Based Microrobot for Removal of SARS-CoV-2 in Wastewater. Journal of the American Chemical Society 143:31, pages 12194-12201.
Crossref
Rafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, Laura Pérez-Alós, Cecilie Bo Hansen, Laust Bruun Johnsen, Charlotte Helgstrand, Franziska Zosel, Jais Rose Bjelke, Fredrik Kryh Öberg, Max Søgaard, Søren R. Paludan, Theresa Bak-Thomsen, Joseph G. Jardine, Mikkel-Ole Skjoedt & Peter Garred. (2021) SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain. The Journal of Immunology 207:3, pages 878-887.
Crossref
Thankamani Karthika, Jeswin Joseph, V. R. Akshay Das, Niranjana Nair, Packirisamy Charulekha, Melvin Daniel Roji & V. Stalin Raj. (2021) SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling. Cells 10:7, pages 1814.
Crossref
Aria C. Shi & Ping Ren. (2021) SARS-CoV-2 serology testing: Progress and challenges. Journal of Immunological Methods 494, pages 113060.
Crossref
Natalia Kruglova, Andrei Siniavin, Vladimir Gushchin & Dmitriy Mazurov. (2021) Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera. Viruses 13:6, pages 1133.
Crossref
Sicong Yu, Keda Chen, Lei Fang, Haiyan Mao, Xiuyu Lou, Chaonan Li & Yanjun Zhang. (2021) Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans. Vaccines 9:6, pages 588.
Crossref
Jingyou Yu, Zhenfeng Li, Xuan He, Makda S. Gebre, Esther A. Bondzie, Huahua Wan, Catherine Jacob-Dolan, David R. Martinez, Joseph P. Nkolola, Ralph S. Baric & Dan H. Barouch. (2021) Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. Journal of Virology 95:11.
Crossref
Lei Bai, Yongliang Zhao, Jiazhen Dong, Simeng Liang, Ming Guo, Xinjin Liu, Xin Wang, Zhixiang Huang, Xiaoyi Sun, Zhen Zhang, Lianghui Dong, Qianyun Liu, Yucheng Zheng, Danping Niu, Min Xiang, Kun Song, Jiajie Ye, Wenchao Zheng, Zhidong Tang, Mingliang Tang, Yu Zhou, Chao Shen, Ming Dai, Li Zhou, Yu Chen, Huan Yan, Ke Lan & Ke Xu. (2021) Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Research 31:4, pages 395-403.
Crossref
Shuai Ge, Xiangjun Wang, Yajing Hou, Yuexin Lv, Cheng Wang & Huaizhen He. (2021) Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2. European Journal of Pharmacology 896, pages 173897.
Crossref
Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth H. Nissly, Denver Greenawalt, Ian M. Bird, Catherine M. Herzog, Matthew J. Ferrari, Indira Poojary, Robab Katani, Scott E. Lindner, Allen M. Minns, Randall Rossi, Paul A. Christensen, Brian Castillo, Jian Chen, Todd N. Eagar, Xin Yi, Picheng Zhao, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, Suresh V. Kuchipudi, James M. Musser & Vivek Kapur. (2021) Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy. Communications Biology 4:1.
Crossref
Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, Sheng-Xiang Ge, Hui-Ming Ye, Jun Zhang, Quan Yuan, Tian-Ying Zhang & Ning-Shao Xia. (2021) Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro. Frontiers in Pharmacology 11.
Crossref
Yali Zhang, Shaojuan Wang, Yangtao Wu, Wangheng Hou, Lunzhi Yuan, Chenguang Shen, Juan Wang, Jianghui Ye, Qingbing Zheng, Jian Ma, Jingjing Xu, Min Wei, Zonglin Li, Sheng Nian, Hualong Xiong, Liang Zhang, Yang Shi, Baorong Fu, Jiali Cao, Chuanlai Yang, Zhiyong Li, Ting Yang, Lei Liu, Hai Yu, Jianda Hu, Shengxiang Ge, Yixin Chen, Tianying Zhang, Jun Zhang, Tong Cheng, Quan Yuan & Ningshao Xia. (2020) Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors. Small Methods 5:2.
Crossref
Endah Puji Septisetyani, Pekik Wiji Prasetyaningrum, Khairul Anam & Adi Santoso. (2021) SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD. Immune Network 21:6.
Crossref
Cecilia Genova, Alex Sampson, Simon Scott, Diego Cantoni, Martin Neto, Emma Bentley, Giada Mattiuzzo, Edward Wright, Mariliza Derveni, Bethany Auld, Bill Ferrara, Dale Harrison, Mohamed Said, Arwa Selim, Elinor Thompson, Craig Thompson, George Carnell & Nigel Temperton. (2021) Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes. BIO-PROTOCOL 11:21.
Crossref
Maria Lay Mendoza, Marissa Acciani, Courtney Levit, Christopher Santa Maria & Melinda Brindley. (2020) Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins. Viruses 12:12, pages 1457.
Crossref
David S. Khoury, Adam K. Wheatley, Mitchell D. Ramuta, Arnold Reynaldi, Deborah Cromer, Kanta Subbarao, David H. O’Connor, Stephen J. Kent & Miles P. Davenport. (2020) Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nature Reviews Immunology 20:12, pages 727-738.
Crossref
yong tang, Ying Zhang, Yixiao Chen, Yizhe Li, Yong He, Jinyong He, Xiaoli Zhang, Zhixing Gao & Jianhua Xu. (2022) A Visual Immunochromatographic Assay for Rapid Detection of SARS-CoV-2 Neutralizing Antibody. SSRN Electronic Journal.
Crossref
José Antonio Cruz-Cardenas, Michelle Gutierrez-Mayret, Alejandra López-Arredondo, Julio Enrique Castañeda-Delgado, Augusto Rojas-Martinez, Gerardo García-Rivas, José Antonio Enciso-Moreno, Laura A. Palomares & Marion Brunck. (2022) A Safe Pseudotyped Lentivirus-Based Assay to Titer SARS-CoV-2 Neutralizing Antibodies. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.